148 related articles for article (PubMed ID: 8997167)
1. Studies on bone markers and bone mineral density in patients with chronic renal failure.
Ha SK; Park CH; Seo JK; Park SH; Kang SW; Choi KH; Lee HY; Han DS
Yonsei Med J; 1996 Oct; 37(5):350-6. PubMed ID: 8997167
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure.
Rix M; Andreassen H; Eskildsen P; Langdahl B; Olgaard K
Kidney Int; 1999 Sep; 56(3):1084-93. PubMed ID: 10469378
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density and biochemical markers of bone metabolism in predialysis patients with chronic kidney disease.
Fidan N; Inci A; Coban M; Ulman C; Kursat S
J Investig Med; 2016 Apr; 64(4):861-6. PubMed ID: 26969749
[TBL] [Abstract][Full Text] [Related]
4. Skeletal status in children and adolescents with chronic renal failure before onset of dialysis or on dialysis.
Pluskiewicz W; Adamczyk P; Drozdzowska B; Szprynger K; Szczepańska M; Halaba Z; Karasek D
Osteoporos Int; 2003 Jun; 14(4):283-8. PubMed ID: 12730774
[TBL] [Abstract][Full Text] [Related]
5. Urinary deoxypyridinoline excretion for the evaluation of bone turnover in chronic renal failure.
Coen G; Mantella D; Calabria S; Sardella D; Manni M; Fassino V; D'Anello E; Giustini M; Taggi F
Am J Nephrol; 2000; 20(4):283-90. PubMed ID: 10970981
[TBL] [Abstract][Full Text] [Related]
6. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density and bone turnover markers in children with chronic renal failure.
Bakr AM
Pediatr Nephrol; 2004 Dec; 19(12):1390-3. PubMed ID: 15517415
[TBL] [Abstract][Full Text] [Related]
8. Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis.
Lane NE; Sanchez S; Genant HK; Jenkins DK; Arnaud CD
Osteoporos Int; 2000; 11(5):434-42. PubMed ID: 10912846
[TBL] [Abstract][Full Text] [Related]
9. Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients.
Doumouchtsis KK; Kostakis AI; Doumouchtsis SK; Tziamalis MP; Stathakis CP; Diamanti-Kandarakis E; Dimitroulis D; Perrea DN
J Bone Miner Metab; 2008; 26(1):66-72. PubMed ID: 18095066
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral densitometry in patients on hemodialysis: difference between genders and what to measure.
Orlic L; Crncevic Z; Pavlovic D; Zaputovic L
Ren Fail; 2010 Jan; 32(3):300-8. PubMed ID: 20370444
[TBL] [Abstract][Full Text] [Related]
11. The role of DEXA bone densitometry in evaluating renal osteodystrophy in continuous ambulatory peritoneal dialysis patients.
Johnson DW; McIntyre HD; Brown A; Freeman J; Rigby RJ
Perit Dial Int; 1996; 16(1):34-40. PubMed ID: 8616170
[TBL] [Abstract][Full Text] [Related]
12. Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables.
Terzi T; Terzi M; Tander B; Cantürk F; Onar M
J Clin Neurosci; 2010 Oct; 17(10):1260-4. PubMed ID: 20619660
[TBL] [Abstract][Full Text] [Related]
13. Total and regional bone mineral density by dual photon absorptiometry in patients on maintenance hemodialysis.
Asaka M; Iida H; Entani C; Fujita M; Izumino K; Takata M; Seto H; Sasayama S
Clin Nephrol; 1992 Sep; 38(3):149-53. PubMed ID: 1395168
[TBL] [Abstract][Full Text] [Related]
14. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
15. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.
Coen G; Ballanti P; Bonucci E; Calabria S; Centorrino M; Fassino V; Manni M; Mantella D; Mazzaferro S; Napoletano I; Sardella D; Taggi F
Nephrol Dial Transplant; 1998 Sep; 13(9):2294-302. PubMed ID: 9761512
[TBL] [Abstract][Full Text] [Related]
16. Profile of chronic kidney disease related-mineral bone disorders in newly diagnosed advanced predialysis diabetic kidney disease patients: A hospital based cross-sectional study.
Ray S; Beatrice AM; Ghosh A; Pramanik S; Bhattacharjee R; Ghosh S; Raychaudhury A; Mukhopadhyay S; Chowdhury S
Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S931-S937. PubMed ID: 28728874
[TBL] [Abstract][Full Text] [Related]
17. Total and regional bone densities in dialysis patients.
Chan TM; Pun KK; Cheng IK
Nephrol Dial Transplant; 1992; 7(8):835-9. PubMed ID: 1325617
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of bone mineral density in CAPD patients with dual energy X-ray absorptiometry.
Pasadakis P; Thodis E; Mourvati E; Euthimiadou A; Margaritis D; Manavis J; Vargemezis V
Adv Perit Dial; 1996; 12():245-9. PubMed ID: 8865913
[TBL] [Abstract][Full Text] [Related]
19. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients.
Scillitani A; Chiodini I; Carnevale V; Giannatempo GM; Frusciante V; Villella M; Pileri M; Guglielmi G; Di Giorgio A; Modoni S; Fusilli S; Di Cerbo A; Liuzzi A
J Bone Miner Res; 1997 Oct; 12(10):1729-36. PubMed ID: 9333135
[TBL] [Abstract][Full Text] [Related]
20. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
